NMD4C Receive Excellence in Service Delivery Award and Network Investigators Honored as part of Muscular Dystrophy Canada’s 2024 Dr David Green Awards

We are excited to share that the NMD4C has been awarded the Excellence in Service Delivery Award, one of the annual Dr David Green Awards presented by Muscular Dystrophy Canada (MDC). Each year MDC presents their esteemed Dr David Green Awards to groups and individuals who have shown exceptional commitment to improving the lives of Canadians affected by NMDs. We are honored to receive the Excellence in Service Delivery Award for 2024 and are excited to continue working with MDC and the entire Canadian neuromuscular community to fulfill our network mission to improve the care, research, and treatment of NMDs for all Canadians.


NMD4C Investigators Receiving a Dr. David Green Award

As an academic research network, we rely on the incredible team of investigators who are the driving force behind our work and are thrilled to see several NMD4C investigators receive individual awards recognizing their contributions to the neuromuscular community! Congratulations to Dr Jodi Warman Chardon, Dr Erin O’Ferrall, and Dr Cam-Tu Émilie Nguyen, who each received a Dr David Green Award:


Dr. Jodi Warman Chardon - NMD4C investigator and steering committee member

Dr Jodi Warman-Chardon, recipient of the 2024 Dr George Karpati Award for Researcher of the Year 




Dr Erin O'Ferrall

Dr Erin O’Ferrall, recipient of the Outstanding Healthcare Partner Award 





Dr Cam-Tu Émilie Nguyen, recipient of the Rising Clinician/Researcher Award 





Read the full news release from MDC to see the full list of award winners!. 

2024 Dr David Green Award winners from MDC

Read next...

Spinal muscular atrophy outcome measures training registration open for December 3rd event.

Spinal Muscular Atrophy Outcome Measures Workshop (English Language)

The NMD4C will be hosting an English-language interactive training workshop on standardizing assessment practices in SMA outcome measures. 

Canadian Neuromuscular Community of Practice

NMD4C Launch Survey to Assess Familiarity and Experience in Outcome Measures in NMDs

As we anticipate novel treatments for other neuromuscular conditions, we would like to understand your familiarity and experience with the outcome measures in clinical trials underway or for treatments for NMDs approved in other jurisdictions through a short survey.


Dr. Cynthia Gagnon Receives 2024 Steinert Award, IDMC-15 Meeting to Take Place in Saguenay 

We are pleased to share that NMD4C steering committee member Dr. Cynthia Gagnon was honoured with a Steinert Award at the recent International Myotonic Dystrophy Consortium Meeting (IDMC-14) in Nijmegen, Netherlands! 

NMD4C logo with text reading 'Canadian neuromuscular clinical trials network', MDC and IMHA logos at bottom.

NMD4C Launch Canadian Neuromuscular Clinical Trial Network

We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.

Event organizers and participants from SMA outcome measures training, March 2024 in Quebec.

Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network

This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted. 

MDC award $900 000 towards clinical and translational research projects in 2024.

MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants

Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects.